Chemotherapy Plus Monoclonal Antibody Therapy in Treating Women With Stage II or Stage IIIA Breast Cancer That Overexpresses HER2

NCT00003992 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

200

Enrollment

NIH

Sponsor class

Conditions

Breast Cancer

Interventions

BIOLOGICAL: trastuzumab
DRUG: cyclophosphamide
DRUG: doxorubicin hydrochloride
DRUG: paclitaxel
DRUG: tamoxifen citrate

Sponsor

National Cancer Institute (NCI)